ArticleFrontiers in endocrinology2026
Acupuncture for ovulation induction in polycystic ovary syndrome: study protocol for a multicenter, randomized, sham-controlled trial.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to 15% of reproductive-aged women, and is characterized by chronic anovulation that leads to irregular menstrual cycles, infertility, and long-term health risks. While acupuncture has been used for ovulation induction in PCOS, existing evidence remains inconclusive due to methodological limitations and clinical heterogeneity of enrolled populations, which have been largely overlooked. This trial aims to evaluate the efficacy of manual acupuncture for improving ovulation in a precisely defined, more homogeneous PCOS subgroup. Methods and analysis: This is a prospective, multicenter, randomized, sham-controlled trial. A total of 156 participants with PCOS will be randomly assigned at a 1:1 ratio to receive either manual acupuncture (MA) or sham acupuncture (SA). Eligible participants present with spontaneous menstrual cycles lasting 35-60 days and a body mass index (BMI) below 28.0 kg/m², and this trial targets a subgroup of patients with mild-to-moderate ovulatory dysfunction. The intervention lasts 12 weeks and comprises 36 treatment sessions (three sessions weekly), after which participants will enter a 12-week follow-up phase. The primary outcome is the cycle ovulation rate (COR) at Week 12, verified via transvaginal ultrasound. Secondary outcomes include menstrual cycle characteristics, reproductive hormone profile, metabolic parameters, anthropometric measures, quality of life, anxiety and depression, patient global impression of change, and safety outcomes. Intention-to-treat analysis will be performed, and a p-value <0.05 (two-sided) will be defined as the threshold for statistical significance. Systematic Review registration: https://itmctr.ccebtcm.org.cn/mgt/project/, identifier ITMCTR2025000078.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.